Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Ulcerative Colitis Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of ulcerative colitis globally
5.1.1.2. Robust availability of healthcare facilities and evolving drug development sector
5.1.1.3. Availability of patient assistance programs and reimbursement policies
5.1.2. Restraints
5.1.2.1. Fluctuating cost of raw materials
5.1.3. Opportunities
5.1.3.1. Ongoing research and development in the production of novel drugs
5.1.3.2. Increasing public and private organization involvement in research of biologics
5.1.4. Challenges
5.1.4.1. Strict government mandates in approval of biosimilars
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Ulcerative Colitis Market, by Drug
6.1. Introduction
6.2. Anti-Inflammatory Drugs
6.3. Anti-TNF Biologics
6.4. Calcineurin Inhibitors
6.5. Immunosuppressant

7. Ulcerative Colitis Market, by Disease
7.1. Introduction
7.2. Fulminant Colitis
7.3. Left-Sided Colitis
7.4. Pancolitis or Universal Colitis
7.5. Proctosigmoiditis
7.6. Ulcerative Proctitis

8. Ulcerative Colitis Market, by Route of Administration
8.1. Introduction
8.2. Injectable
8.3. Oral

9. Americas Ulcerative Colitis Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Ulcerative Colitis Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Ulcerative Colitis Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. AbbVie Inc.
13.1.3. AstraZeneca PLC
13.1.4. Bausch Health Companies Inc.
13.1.5. BioLineRx Ltd
13.1.6. Boehringer Ingelheim GmbH
13.1.7. Celgene Corporation
13.1.8. Circle33, LLC
13.1.9. Cosmo Pharmaceuticals NV
13.1.10. Eli Lilly and Company
13.1.11. GlaxoSmithKline Plc
13.1.12. Johnson & Johnson Services, Inc.
13.1.13. Merck & Co., Inc.
13.1.14. Mitsubishi Tanabe Pharma Corporation
13.1.15. Pfizer Inc.
13.1.16. Sanofi SA
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. ULCERATIVE COLITIS MARKET RESEARCH PROCESS
FIGURE 2. ULCERATIVE COLITIS MARKET SIZE, 2023 VS 2030
FIGURE 3. ULCERATIVE COLITIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ULCERATIVE COLITIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ULCERATIVE COLITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ULCERATIVE COLITIS MARKET DYNAMICS
FIGURE 7. ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 8. ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ULCERATIVE COLITIS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ULCERATIVE COLITIS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ULCERATIVE COLITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. ULCERATIVE COLITIS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ULCERATIVE COLITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 6. ULCERATIVE COLITIS MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ULCERATIVE COLITIS MARKET SIZE, BY ANTI-TNF BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ULCERATIVE COLITIS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ULCERATIVE COLITIS MARKET SIZE, BY IMMUNOSUPPRESSANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 11. ULCERATIVE COLITIS MARKET SIZE, BY FULMINANT COLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ULCERATIVE COLITIS MARKET SIZE, BY LEFT-SIDED COLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ULCERATIVE COLITIS MARKET SIZE, BY PANCOLITIS OR UNIVERSAL COLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ULCERATIVE COLITIS MARKET SIZE, BY PROCTOSIGMOIDITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ULCERATIVE COLITIS MARKET SIZE, BY ULCERATIVE PROCTITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 17. ULCERATIVE COLITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ULCERATIVE COLITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 30. CANADA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 31. CANADA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 33. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ULCERATIVE COLITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 47. CHINA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 48. CHINA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 50. INDIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 51. INDIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 56. JAPAN ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 74. THAILAND ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ULCERATIVE COLITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 84. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 87. EGYPT ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 90. FINLAND ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 93. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 102. ITALY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 103. ITALY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 111. NORWAY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 114. POLAND ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 115. POLAND ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 117. QATAR ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 118. QATAR ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 129. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 138. TURKEY ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM ULCERATIVE COLITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 146. ULCERATIVE COLITIS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 147. ULCERATIVE COLITIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. ULCERATIVE COLITIS MARKET LICENSE & PRICING